The UK drugmaker will pay $1 billion upfront for IDRx, whose lead drug for gastrointestinal tumors shows potential against ...

The 30th edition of the Dubai International Pharmaceuticals and Technologies Conference and Exhibition - DUPHAT 2025 concluded successfully, recording AED9.35 billion in direct and indirect trade ...

GSK-3536819 (MenABCWY) developed by GSK plc | Meningococcus GSK plc's GSK-3536819 vaccine candidate, a 5-in-1, first-generation formulation, targets the five groups of Neisseria meningitidis (A, B, C, ...

Where: 3rd and 4th Floor, Jollygunj, 17/A, 15th Cross, Outer Ring Road, 3rd Phase, JP Nagar, Karnataka, JP Nagar, Bangalore There’s nothing South Bengalureans love more than a good breakfast! Ask me!

Bengaluru: Bangalore Development Authority (BDA) has decided to develop six residential layouts with 50,000 sites along the proposed Peripheral Ring Road (PRR)-2 that seeks to link Hosur Road to ...

Bangalore Truck Collision News: The Bengaluru rural district police are searching for a blue car believed to have caused the accident that killed a software company chief, his wife, their two children ...

The group has announced a $45 million upfront deal, including a $15 million equity investment with UK pharma group GSK (LSE: GSK). GSK is partnering with Relation to discover new targets for fibrotic ...

Kathyayini Chamaraj, executive trustee of CIVIC Bangalore who has spearheaded the online campaign, argues that these projects cater primarily to the city’s 23 lakh private car owners, representing a ...

So, the golden question arises, where can you stock up on your Christmas goodies in Bangalore? Well, let’s help you make your Christmas merrier. Here are the 12 best places in the hood to get the best ...

(RTTNews) - GSK plc (GSK, GSK.L) reported headline results from the FIRST-ENGOT-OV44 phase III trial evaluating Zejula and Jemperli in first line advanced ovarian cancer. The trial met its primary ...

Dec 20 (Reuters) - GSK (GSK.L), opens new tab said on Friday that adding its cancer drug Jemperli to both standard-of-care chemotherapy and Zejula as a maintenance therapy improved survival in ...

First approved in 2021, Jemperli has now become a cornerstone of GSK’s cancer business, earning more than $160 million in the third quarter. GSK on Friday unveiled headline findings from the Phase III ...